Listing 1 - 2 of 2 |
Sort by
|
Choose an application
Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this text explores the conflicting priorities and aims of the biopharmaceutical industry.
Economics, Pharmaceutical. --- Drug Approval. --- Marketing --- Drug Industry. --- Public Policy. --- economics. --- Affirmative Action --- Migration Policy --- Population Policy --- Social Protection --- Social Policy --- Action, Affirmative --- Migration Policies --- Policies, Migration --- Policies, Population --- Policies, Public --- Policies, Social --- Policy, Migration --- Policy, Population --- Policy, Public --- Policy, Social --- Population Policies --- Protection, Social --- Public Policies --- Social Policies --- Policy Making --- Social Control, Formal --- Industries, Pharmaceutic --- Industry, Drug --- Industry, Pharmaceutic --- Industry, Pharmaceutical --- Pharmaceutical Industry --- Drug Industries --- Industries, Drug --- Industries, Pharmaceutical --- Pharmaceutic Industries --- Pharmaceutic Industry --- Pharmaceutical Industries --- Food and Drug Administration Drug Approval --- Food and Drug Administration Drug Approval Process --- New Drug Approval Process --- Drug Approval Process --- New Drug Approval --- Approval Process, Drug --- Approval Processes, Drug --- Approval, Drug --- Approval, New Drug --- Approvals, Drug --- Approvals, New Drug --- Drug Approval Processes --- Drug Approval, New --- Drug Approvals --- Drug Approvals, New --- New Drug Approvals --- Process, Drug Approval --- Processes, Drug Approval --- Clinical Trials as Topic --- Off-Label Use --- Pharmacy Economics --- Pharmaceutical Economics --- Pharmacoeconomics --- Economic, Pharmacy --- Economics, Pharmacy --- Pharmacy Economic --- Pharmacy --- economics
Choose an application
Pharmaceutical Economics and Policy provides comprehensive discussions on a wide range of pharmaceutical economics and policy issues. This third edition re-examines ongoing issues such as industrial organization, R&D and innovation, competition and pricing, intellectual property and regulation. It also includes a number of new topics, such as the nascent biosimilar sector, globalization of supply chain, value-based pricing, evolving reimbursement landscape, and the emerging pharmaceutical market in large, developing economies such as China and India.
Listing 1 - 2 of 2 |
Sort by
|